General Oncology, Inc., a clinical-stage biopharmaceutical company creating medicines for metastatic cancers, announced the appointment of Abid Ansari as Chief Financial Officer (CFO).  Abid brings over 20 years of experience in the biotechnology sector, including eight years as a CFO. He has expertise in financial strategy and corporate development for public and private life science companies.  He has led multiple successful capital-raising initiatives, including initial public offe...